AngioDynamics Inc (ANGO)
6.04
-0.38
(-5.92%)
USD |
NASDAQ |
May 17, 16:00
6.05
+0.01
(+0.17%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (Annual): 29.88M for May 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| May 31, 2023 | 29.88M |
| May 31, 2022 | 30.74M |
| May 31, 2021 | 36.39M |
| May 31, 2020 | 29.68M |
| May 31, 2019 | 28.26M |
| May 31, 2018 | 24.34M |
| May 31, 2017 | 24.15M |
| May 31, 2016 | 25.05M |
| May 31, 2015 | 26.59M |
| May 31, 2014 | 28.12M |
| May 31, 2013 | 26.32M |
| May 31, 2012 | 20.51M |
| Date | Value |
|---|---|
| May 31, 2011 | 21.37M |
| May 31, 2010 | 19.28M |
| May 31, 2009 | 17.91M |
| May 31, 2008 | 14.42M |
| May 31, 2007 | 20.56M |
| May 31, 2006 | 5.869M |
| May 31, 2005 | 4.57M |
| May 31, 2004 | 3.551M |
| May 31, 2003 | 2.509M |
| May 31, 2002 | 1.951M |
| May 31, 2001 | 1.426M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
28.26M
Minimum
2019
36.39M
Maximum
2021
30.99M
Average
29.88M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Becton Dickinson & Co | 1.237B |
| Outset Medical Inc | 57.31M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |